Exchange Bulletin

KNIGHT THERAPEUTICS INC. ("GUD")
BULLETIN TYPE: New Listing-Shares, Halt
BULLETIN DATE: February 27, 2014
TSX Venture Tier 2 Company

The common shares of Knight Therapeutics Inc. (the "Company") will be listed and admitted to trading on TSX Venture Exchange, on the effective dates stated below.

The Company is classified as a "Pharmaceutical and Pharmacy Supplies Wholesaler - Distributors" company (NAICS number 414510).

The Company was created as a wholly-owned subsidiary of Paladin Labs Inc. ("Paladin"), which transferred all its rights associated with Impavido (miltefosine), a product indicated for the treatment of leishmaniasis, in exchange for 22,036,060 common shares of the Company, all of which will be distributed to Paladin securityholders following a plan of arrangement (the "Arrangement") expected to be effective before the market opening on Friday, February 28, 2014 and on the basis of 1 common share of the Company for each common share or in the money option of Paladin.

Listing Date: At the close of business (5:01 p.m. EST) on Thursday, February
27, 2014.
Trading Halt: At the opening on Friday, February 28, 2014

It is expected that the ordinary shares of Endo International plc, the
resulting issuer from the Arrangement, will be posted for trading on Toronto Stock Exchange ("TSX") at the opening on Monday, March 3, 2014. Therefore trading on the common shares of Knight Therapeutics Inc. will be HALTED at the opening on Friday, February 28, 2014, pending confirmation of closing of the Arrangement. It is expected that trading will resume at the opening on Monday, March 3, 2014. A further notice will be issued upon receipt of confirmation of closing of the Arrangement.

Commence Date: The common shares of the Company will commence trading on TSX Venture Exchange at the opening on Monday, March 3, 2014, subject to confirmation of closing of the Arrangement.

Corporate Jurisdiction: Canada

Capitalization: Unlimited common shares with no par value of which
22,036,060 common shares are issued and outstanding
Escrow Nil shares

Transfer Agent: Computershare Investor Services Inc. (Montreal and Toronto)
Trading Symbol: GUD
CUSIP Number: 499053106
Sponsoring Member: Cormark Securities Inc.

For further information, please refer to the Company's Listing Application
dated February 21, 2014 available on SEDAR.

Company Contact: Jonathan Ross Goodman
Company Address: 102-6111 Royalmount Avenue
Montreal, Quebec H4P 2T4
Company Phone Number: 514-669-5372
Company Fax Number: 514-344-4675
Company Website: www.gud-knight.com
Company Email Address: jgoodman@gud-knight.com